Chief among them are FOXP3+ regulatory T-cells (Tregs), which are enriched in poorly differentiated, metastatic, or transplant-related cSCC [33,39,42], exerting suppression through cytokine production and checkpoint signaling. The gene discussed is FOXP3; the disease is skin squamous cell carcinoma.